MedPath

Treatment using N-acetyl cysteine (Injection) to reduce occurrence of muscle weakness and death in patients admitted with organophosphate (OP) pesticide poisoning.

Phase 2
Conditions
Health Condition 1: T600- Toxic effect of organophosphate and carbamate insecticides
Registration Number
CTRI/2020/09/028060
Lead Sponsor
Christian medical college Vellore
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Inclusion criteria

The diagnosis of Organophosphate Poisoning made on the basis of typical clinical toxidrome of cholinergic and nicotinic manifestations and

Reliable identification of the compound ingested on the basis of the container brought by the patients attendants or

A subsequent confirmation of significant exposure based on suppression of serum pseudocholinesterase levels to less than 1000 U per L

Exclusion Criteria

Presentation more than 48 hours of having consumed the organophosphate compound (late presenters)

Those suspected to have a mixed or polysubstance overdose (other than ethanol and pyrethroid).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure was incidence of Intermediate Syndrome (IMS).Timepoint: At baseline, day 3 day 5 and discharge
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath